Graystone reported today that its spinoff, Sparrow Innovations, a leading innovator in medical products and solutions, announced the approval of the nomination of Dr. Linda Denno as the new Chief Executive Officer and Chairman of the Board.
Dr. Denno brings extensive experience in advanced research and design, legal compliance, program management, human resources, and administration to the team. Her broad research on a variety of topics and various talents are a key asset to the developing company.
She has worked with local state legislators, members of Congress, and other public officials in addition to serving as a director for several non-profit corporations. She has directed and administered federal and state programs, negotiated federal contracts, and successfully lobbied public officials for increased funding and programmatic authorizations.
Under Dr. Denno’s leadership, Sparrow Innovations will implement a new strategy and vision, which is to be the standard of excellence in the patient monitoring market. Dr. Denno will be committed to reorganizing the company to enhance corporate performance by utilizing a stronger industry focus, a worldwide Sparrow Innovations branding campaign, and an uncompromising commitment to corporate social responsibility.
Let us hear your thoughts below: